Thirty years ago, diagnosing glaucoma progression meant comparing hand-drawn visual field maps from visit to visit. Today, OCT scans measure the retinal nerve fiber layer to within 5 microns — thinner than a human hair. That precision changed what’s possible in early disease detection. It also changed your copay.
Understanding what you’re actually paying for helps you evaluate whether your ophthalmologist’s recommendation for repeat scanning is clinically justified — or whether it’s being overused.
What OCT Actually Does
Optical Coherence Tomography uses near-infrared light to create cross-sectional images of tissue — essentially the optical equivalent of ultrasound, but with far higher resolution. The instrument fires a beam of light into the eye and measures the time it takes for reflections to return from different tissue layers.
The result is a detailed cross-sectional map of the retina — all ten distinct layers — with resolution in the 5–15 micron range. For context, a human hair is approximately 70 microns thick. OCT can detect changes in retinal tissue thinner than a fraction of a hair.
The AAO’s technology assessment of OCT describes it as the most significant advance in ophthalmic diagnostic imaging since the introduction of fluorescein angiography in the 1960s.
What OCT Scans in Different Clinical Contexts
| Clinical Application | What’s Imaged | Key Measurement |
|---|---|---|
| Glaucoma | Retinal nerve fiber layer (RNFL), optic nerve head | RNFL thickness — loss indicates glaucomatous damage |
| Age-related macular degeneration | Macula — drusen, fluid, RPE integrity | Sub-retinal/intra-retinal fluid presence; geographic atrophy area |
| Diabetic macular edema | Macula — retinal thickness, intra-retinal cysts | Central subfield thickness (CST) — triggers injection treatment |
| Epiretinal membrane | Retinal surface, macular contour | Membrane visibility, central thickness, distortion |
| Optic neuritis | Optic nerve and RNFL | RNFL thinning as sequela of inflammation |
| Corneal disease | Anterior segment (requires different OCT lens) | Corneal thickness, angle anatomy |
How OCT Changed Glaucoma Management
The impact on glaucoma care deserves specific attention. Research published in the journal Ophthalmology has demonstrated that OCT can detect structural nerve fiber layer loss 3–5 years before that loss becomes detectable on visual field testing. This is a fundamental shift in how early glaucoma is caught.
Before OCT, glaucoma was often not detected until patients had already lost meaningful visual field — a function that doesn’t recover. OCT lets ophthalmologists identify glaucomatous nerve damage while the patient still has completely normal visual fields, enabling treatment to begin before irreversible functional loss occurs.
The NEI’s glaucoma research program has supported multiple studies confirming that OCT-based structural monitoring, combined with visual field testing, gives the most complete picture of glaucoma progression. Using only one or the other misses information.
These two tests measure different things and are complementary, not redundant.
OCT (structural): Measures the thickness of the nerve fiber layer and ganglion cell complex — the physical tissue. Loss shows up on OCT years before it affects function.
Visual field (functional): Measures what the patient can actually see across their field of vision. More relevant to daily life impact; more variable from test to test.
In glaucoma management, both are needed. An OCT showing stable RNFL with a worsening visual field (or vice versa) each tells a different clinical story. The AAO’s Preferred Practice Pattern for glaucoma recommends regular monitoring with both instruments.
Cost by Setting and Indication
| Setting | Standard OCT Cost | OCT-A Cost |
|---|---|---|
| Ophthalmology office | $50–$150 | $75–$200 |
| Optometry office | $75–$150 | $100–$200 |
| Hospital-based eye clinic | $100–$250 | $150–$300 |
| Medicare patient (20% + deductible) | $10–$30 per scan | $15–$40 |
| Without insurance, no established diagnosis | Full $75–$150 | Full $100–$200 |
OCT is usually performed at every ophthalmology visit for patients with glaucoma or macular disease — not as an annual scan, but as often as every 3–4 months in progressive disease. For stable conditions, twice yearly is typical.
When Insurance Pays — and When It Doesn’t
Medicare and most private insurers cover OCT when it’s performed for a diagnosed medical condition. The key distinction:
Covered: OCT for established glaucoma, AMD, diabetic macular edema, epiretinal membrane, macular hole, optic nerve disease, uveitis complications, and other diagnosed conditions. Billed under codes 92134 (glaucoma RNFL), 92135 (retina), or related codes depending on indication.
Not automatically covered: OCT performed purely for screening or wellness purposes when no condition has been diagnosed. If you have no established diagnosis and your ophthalmologist includes OCT in a routine exam, you may be billed separately — typically $75–$150.
The high-risk patient scenario: Some practices offer OCT to patients with strong family history of glaucoma or AMD as a screening measure. This may not be covered. Ask your practice manager before the scan what will be billed to insurance and what your expected out-of-pocket will be.
OCT-A (angiography) is less consistently covered than standard OCT. Some insurers classify it as investigational or require prior authorization. Check before assuming it’s included.
How Often You Really Need It
Frequency should match your diagnosis and disease stage — not a fixed schedule:
- No known eye disease: Not routinely needed; OCT during comprehensive exam is discretionary
- Glaucoma suspect / ocular hypertension: Annually in most cases
- Stable early glaucoma: Every 6 months for structural monitoring
- Progressive or moderate/advanced glaucoma: Every 3–4 months — more data points allow earlier detection of worsening and faster treatment adjustment
- AMD (dry, stable): Every 6–12 months; immediately with any new symptoms
- AMD (wet, on injections): Typically before every injection visit (every 4–12 weeks)
- Diabetic macular edema: Every 3–4 months during active treatment; less frequent when stable
If you’re paying out-of-pocket for routine OCT at every eye exam without a diagnosed condition, ask whether the scan is changing clinical decisions or serving primarily as a baseline reference. OCT for screening purposes in low-risk, young, healthy patients has unclear cost-effectiveness. In contrast, OCT for any patient over 60 with diabetes, family history of glaucoma, or elevated eye pressure has clear clinical value. Know why the test is being ordered.
Bottom Line
An OCT scan costs $50–$150, with Medicare patients typically paying $10–$30 after coverage. It’s the most important diagnostic tool in modern ophthalmology — detecting glaucomatous nerve loss 3–5 years before visual field changes, mapping macular disease to the micron level, and guiding injection treatment for AMD and diabetic macular edema. It’s covered by Medicare and most insurers for diagnosed conditions; screening OCT in healthy patients without a diagnosis is typically a full out-of-pocket expense. If you have glaucoma, AMD, or diabetic eye disease, regular OCT isn’t optional — it’s the primary tool your ophthalmologist uses to know whether your treatment is working.
Frequently Asked Questions
Medicare Part B covers OCT when medically necessary for a diagnosed condition — glaucoma, age-related macular degeneration, diabetic macular edema, epiretinal membrane, and similar diagnoses. Coverage is 80% of the approved amount after the annual deductible, leaving patients responsible for roughly $10–$30 per scan. If you're having OCT for general screening purposes without an established diagnosis, you'll typically pay the full $75–$150 out-of-pocket.
An OCT scan takes about 5–10 minutes including setup. It doesn't require dilation — no eye drops, no waiting 20–30 minutes for pupils to dilate, no blurry vision afterward. The instrument uses near-infrared light and works through an undilated pupil in most patients. Some practitioners dilate first to improve image quality in patients with small pupils or dense media, but it's not standard for most OCT protocols.
Standard OCT creates cross-sectional structural images of retinal layers — like an ultrasound in 2D cross-section, but using light instead of sound. OCT-A (OCT Angiography) adds functional information about blood flow: it detects motion of red blood cells to visualize retinal and choroidal vessels without injecting any dye. OCT-A costs $75–$200 and is used to evaluate neovascularization in wet AMD, diabetic retinopathy severity, and glaucoma. It doesn't replace fluorescein angiography in all situations, but it's non-invasive and getting better each year.